FIGURE 4-3. Defining the gap in biomedical research, from idea to patent expiration.

FIGURE 4-3Defining the gap in biomedical research, from idea to patent expiration

Celtic Therapeutics funds and facilitates the development of promising product candidates to the point of submission of an NDA or a major increase in value of the potential product.

NOTE: IND = initial new drug; NDA = New Drug Application; POC = proof of concept.

SOURCE: Corr, 2008.

From: 4, Diverse Funding Models

Cover of Breakthrough Business Models
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary.
Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.
Washington (DC): National Academies Press (US); 2009.
Copyright © 2009, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.